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We studied the impact of HIV Nef on CD8þ T cells in a mouse model of AIDS, the CD4C/HIVNef
transgenic (Tg) mice. We found that negative and positive thymic selections of CD8þ T cells proceeded
normally in Nef Tg mice bred respectively with HY or OT-1 TCR Tg mice. Tg peripheral CD8þ T cells
showed an activated phenotype and enhanced cell division in vivo and proliferated efﬁciently when
stimulated in vitro with antigenic peptide. When challenged with LCMVArmstrong, Nef Tg mice developed
a strong acute CD8þ T cell response and cleared the virus as efﬁciently as wild-type mice. However,
maintenance of LCMV-speciﬁc CD8þ memory T cells was impaired in Nef Tg mice, a defect partially
rescued by adoptive transfer of non-Tg naı¨ve CD4þ T cells. Thus, despite severe abnormalities of their
precursors, the double-positive CD4þCD8þ thymocytes, Tg CD8þ T cells have conserved important
functions.
& 2013 Elsevier Inc. All rights reserved.Introduction
The most visible sign of HIV-1 infection is the depletion
of peripheral CD4þ T cells, which represent the main target cells
infected by this virus (Pantaleo, 1997). However, during HIV-1
infection, other cell subsets of the immune system are directly or
indirectly affected. This is the case for CD8þ T cells. Despite the
usual absence of expression of the CD4 receptor for HIV entry,
a minority of these cells have been found to be productively
infected by HIV-1 (Cochrane et al., 2004; Imlach et al., 2001; Saha
et al., 2001), most likely as a result of CD4 expression during their
activation (Flamand et al., 1998; Yang et al., 1998; Imlach et al.,
2001). CD8þ T cells, which are depleted only late during infection
(Roederer et al., 1995; Rabin et al., 1995), are activated (Sodora
and Silvestri, 2008; Giorgi et al., 1993; Doisne et al., 2004; Rabin
et al., 1995; Appay et al., 2002) and show signs of enhanced
apoptosis (Lewis et al., 1994; Herbein et al., 1998; Mueller et al.,
2001) and proliferation/turnover (Benlhassan-Chahour et al.,
2003; Mohri et al., 1998; Monceaux et al., 2003; Rosenzweig
et al., 1998; Sachsenberg et al., 1998; Hellerstein et al., 1999;
Hazenberg et al., 2000; Douek et al., 2001; Lempicki et al., 2000),
both in SIV or HIV infections. Their activation has been found toll rights reserved.
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oeur).be an excellent correlate of progression to AIDS (Liu et al., 1997,
1998; Giorgi et al., 1993, 1999; Deeks et al., 2004). The functions
of CD8þ T cells from HIV-1 infected individuals are also abnormal.
They become defective at producing various antiviral factors, such as
b-chemokines which can bind to the HIV-1 coreceptor, a-defensins or
other(s) (CAF) not yet identiﬁed (Yang and Walker, 1997; Levy et al.,
1996; Zhang et al., 2002). CD8þ T cells from HIV-1 infected
individuals also show a decreased response to stimulation in vitro
(Lewis et al., 1994; Miedema et al., 1988). In vivo, the cytotoxic T cell
(CTL) response of CD8þ T cells to HIV-1 or SIV is initially strong and
represent one of the main controls of viremia following primary
infection (Geretti et al., 1998; Koup et al., 1994; Walker et al., 1987;
Friedrich et al., 2007). However, in most individuals, this HIV-speciﬁc
CD8þ CTL response becomes progressively dysfunctional and/or
exhausted (Lieberman et al., 2001; Carmichael et al., 1993; Klein
et al., 1995). An increase of PD-1, a negative regulatory receptor
associated with T cell exhaustion, has been described during HIV
infection (Zhang et al., 2007; Trautmann et al., 2006; Farrell, 2006).
These changes most likely contribute to the loss of control of viral
replication and progression to AIDS. There is evidence that impaired T
cell memory could contribute to this defect. In HIV-1 infection, central
memory CD8þ T cells are decreased in number and have a shorter
half life (Ladell et al., 2008). This could be a consequence of defective
maturation of HIV-speciﬁc effectors T cells to central memory
phenotype (Champagne et al., 2001; Colle et al., 2006). The above
mentioned changes are, at least initially, speciﬁc for the anti-HIV
CD8þ T cell response. However, abnormal CD8þ T cell responses
Table 1
Transgene expression in CD8þ thymocytes and CD8þ T cells.
Relative HIV Tg expression (%)
CD4þ T cells CD8þ Tcells
Non-Tg 0 0
Nef Tg 100 1.6
Measurement was done by quantitative RT-PCR in sorted-puriﬁed peripheral
CD8þ T cells, as compared to CD4þ T cells (adjusted to 100) of CD4C/HIVNef Tg
mice.
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SIV or HIV infection (Kersten et al., 1997; Bronke et al., 2005; Van
Baarle et al., 2001; Geretti et al., 1996; Piriou et al., 2005b; van et al.,
2002; Kaur et al., 2003), suggesting a more global defect of CD8þ T
cell memory generation.
The mechanisms of these alterations are starting to be dis-
sected. One contributing factor appears to be the lack of CD4þ T
help (Altfeld and Rosenberg, 2000; Rosenberg et al., 1997), which
is important for generation and maintenance of CD8þ memory T
cells in humans (Day et al., 2002; Gamadia et al., 2003) and in
mice (Kaech and Ahmed, 2003; Sun and Bevan 2003; Shedlock
and Shen, 2003). During HIV-1 or SIV infection, correlation has
been observed between loss of CD4þ T cell help and depletion of
CD8þ CTL responses against HIV/SIV itself (Kostense et al., 2001,
2002b; Kalams et al., 1999; Carmichael et al., 1993) or against
viruses other than HIV-1 or SIV (Bronke et al., 2005; van Baarle
et al., 2002; Van Baarle et al., 2001; Spiegel et al., 2000;
Komanduri et al., 2001; Kaur et al., 2003; Kostense et al.,
2002a). In addition, restoration of CD4þ T cell numbers and
functions by anti-retroviral therapy was found to be correlated
with improved anti-HIV-1 (Kostense et al., 2002a; Rosenberg
et al., 2000) and anti-EBV (Piriou et al., 2005a; Dalod et al.,
1999; Kostense et al., 2002a) CD8þ CTL responses. However,
direct experimental evidence for a role of CD4þ T cell help in vivo
could not be obtained in these studies. It is not known either
whether CD8þ T cells are impaired in their positive or negative
thymic selection following HIV-1 infection. Finally, the HIV-1
proteins responsible directly and indirectly for the CD8þ T cells
defects have not been identiﬁed either.
To get answers to these questions, we used a mouse model of
AIDS, the CD4C/HIVNef Tg mice (Jolicoeur, 2011), to study the CD8þ T
cell compartment. The choice of the CD4C regulatory elements from
the human CD4 gene to generate these Tg mice allows Nef to be
expressed in the same target cells as in HIV-infected humans, namely
in CD4þ T cells and in cells of the macrophage/monocyte/dendritic
lineage (Hanna et al., 1994, 2001), in contrast to the more restricted
expression possible with the regulatory sequences of the mouse CD4
gene (Hanna et al., 2009). When expression of HIV genes is restricted
to the cell populations targeted by the CD4C promoter, we found that
Nef was sufﬁcient (and necessary) to induce all of the major
phenotypes elicited by expression of all HIV genes (Hanna et al.,
1998). The immune AIDS-like disease in CD4C/HIVNef Tg mice is
characterized by immunodeﬁciency, thymic atrophy, impaired posi-
tive selection and lineage commitment of CD4þ T cells, loss of
peripheral CD4þ T cells, lower CD4 helper functions, T and B cell
hyperactivation, impaired germinal center formation (Hanna et al.,
1998; Weng et al., 2004; Priceputu et al., 2005; Poudrier et al., 2001;
Chrobak et al., 2010) as well as defects in DC maturation (Poudrier
et al., 2003). These Tg mice also show organ pathologies such as heart
and kidney diseases (Hanna et al., 1998; Kay et al., 2002), which have
been described in human AIDS (Ross and Klotman, 2004; Kamin and
Grinspoon, 2005). All these phenotypes are strikingly similar to those
found in individuals with AIDS, particularly in pediatric AIDS
(Scarlatti, 1996). Finally, at the molecular level, Nef-expressing mouse
CD4þ T and myeloid cells show strong PAK-2 activation, as do Nef-
expressing human cells (Vincent et al., 2006). Hence, our studies and
those of others (Skowronski et al., 1993; Pennington et al., 1997;
Lindemann et al., 1994; Larsen et al., 1998) (reviewed in Klotman and
Notkins, 1996; Brady et al., 1994) have shown that Nef is a major
determinant of pathogenicity in mice, as it is in primates (Kestler
et al., 1991) and human (Deacon et al., 1995).
Because the CD4C/HIVNef Tg mice represent a relevant model
of AIDS pathogenesis, we used them to study the fate of CD8þ T
cells, including the generation of CD8þ memory T cells, in
absence of an acquired CD8þ T cell-mediated immune response
against HIV Nef, most likely tolerized as a transgene expressedearly in the thymus. We report here that CD8þ T cells from these
Tg mice develop relatively normally in thymus, and do not show
major intrinsic abnormalities. However, we found that generation
of CD8þ T cell memory is impaired in these Tg mice and that this
impairment is partly due to defective CD4þ T cell help.Results
Expression of HIV Nef in CD8þ T cells from Tg mice
We previously reported that the CD4C regulatory elements can
drive expression of surrogate genes in a small percentage of CD8þ T
cells (Hanna et al., 2001). To conﬁrm these results, we used an
alternative experimental approach. Peripheral CD8þ T cells were
puriﬁed from CD4C/HIVNef Tg mice by cell sorting and HIV expres-
sion was directly measured by quantitative real-time RT-PCR on
RNA extracted from them. For comparison, control CD4þ T cells
were processed in parallel. Results of this experiment revealed that
the levels of expression of the HIV transgene in CD8þ T cells were
low, o2% of those measured in control CD4þ T cells (Table 1).
These results indicate that only a small percentage of CD8þ T
cells in CD4C/HIVNef Tg mice express HIV-1 Nef at low levels. This
is consistent with the reported low CD4-dependent infection of
CD8þ T cells in patients infected with HIV-1 (Saha et al., 2001;
Imlach et al., 2001; Cochrane et al., 2004).Negative selection of MHC class-I restricted CD8þ T cells is not
affected by HIV-1 Nef in Tg mice
CD8þ T cells develop from the CD4þ8þ DP thymocytes which
have undergone negative and positive selection in the thymus.
In CD4C/HIVNef Tg mice, the transgene is expressed in DP
thymocytes. To determine the effect of HIV-1 Nef expression on
negative selection of MHC class-I restricted thymocytes, CD4C/
HIVNef Tg mice were bred with HY TCR Tg mice. HY TCR Tg mice
express a T-cell receptor (TCR) transgene encoding reactivity to
male antigen HY presented by class-I MHC (Teh et al., 1988). In
male HY TCR Tg mice, the thymus is normally small and
thymocyte numbers are low (Fig. 1A), due to depletion of self-
reactive T-cells. Since adult CD4C/HIVNef Tg mice show patholo-
gies in non-lymphoid organs (Hanna et al., 1998), which could
adversely affect the lymphoid tissues, we analyzed mice before
the appearance of any organ disease. Young (o2 week-old) and
older (6–8 week-old) (CD4C/HIVNef X HY TCR) double Tg male
mice showed lower CD8þ SP and CD4þ8þ DP thymocyte num-
bers compared to female double Tg mice and even to male HY TCR
Tg mice (Fig. 1A and B). CD8þ T cell numbers were similar in the
peripheral lymphoid organs (Fig. 1C). In addition, older (4–6-
week-old) double Tg male mice had severe thymic atrophy (loss
of CD4þ8þ DP thymocytes, Fig. 1A) and splenomegaly (increased
cellularity, Fig. 1C) compared to HY TCR Tg mice, as well as
downregulation of cell surface CD4, depletion of thymic CD4þ SP
Fig. 1. Thymic selection of MHC class-I restricted CD8þ thymocytes: (A) Thymic FACS proﬁles of male HY TcR Tg and male (HY TcR X CD4C/HIVNef ) double Tg mice at o2
weeks and 4–6 weeks of age. Percentage of events in each quadrant is shown as mean7SD (upper panel). Absolute cell numbers of different thymocyte populations in 4–6
weeks old mice are shown in lower panel. (B) Thymic proﬁles of female HY TcR Tg and female (HY TcR X CD4C/HIVNef ) double Tg mice at o2 weeks and 4–6 weeks of age.
Percentage of events in each quadrant is shown as mean7SD (upper panel). Absolute cell numbers of different thymocyte populations in 4–6 weeks old mice are shown in
lower panel. (C) Absolute cell numbers of CD8þ T cells in spleen from 4–6 weeks old male and female mice. (D) FACS proﬁle of spleen from female HY TcR Tg and female
(HY TcR X CD4C/HIVNef ) double Tg mice at o2 weeks and 4–6 weeks of age. Statistical analysis was performed by Student’s t-test and p-values are shown.
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phenotype observed in CD4C/HIVNef Tg mice (Hanna et al., 1998).
Therefore, the self-reactive HY TCR Tg CD4þ8þ DP thymocytes
are depleted efﬁciently in the thymus of DTg male mice, indicating
competent negative selection of class-I restricted CD8þ T cells.
Positive selection of class-I restricted CD8þ T cells proceeds in the
presence of HIV-1 Nef with the accumulation of immature CD8þ SP
thymocytes
Positive selection of CD8þ T cells was ﬁrst studied in female
HY TCR Tg mice, in which HY TCR expressing thymocytes are notnegatively selected. In both young (o2 week-old) and older (6–8
week-old) female (CD4C/HIVNef X HY TCR) double Tg mice,
CD4þ8þ DP thymocytes numbers were lower than in HY TCR
single Tg females, while there was an increase of DN and to
a lesser extent of CD8þ SP thymocytes (Fig. 1B). Surprisingly,
percentage of CD8þ T cells in DTg was much lower in spleen of
younger female (CD4C/HIVNef X HY TCR) double Tg mice, although
they were similar in older female mice compared to HY TCR Tg
female mice (Fig. 1C). In line with this result, we previously
reported splenic CD8þ T cell deﬁciency in young but not adult
CD4C/HIVNef Tg mice (Chrobak et al., 2010). Furthermore, 3
months after transplantation of Tg fetal liver cells into irradiated
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observed in the spleen (Fig. S1). These data demonstrate delayed
kinetics of generation of Tg peripheral CD8þ T cell pool.
OT-1 TCR Tg mice were also used to study positive selection.
These Tg mice express a TCR (Va2Vß5) speciﬁc for the OVA-derived
peptide SIINFEKL (OVAp) presented in the context of H-2Kb and are a
useful model to study thymic positive selection (Clarke et al., 2000).
In (CD4C/HIVNef X OT-1 TCR) double Tg mice, the increase in CD8þ
SP thymocyte numbers was more prominent than in (CD4C/HIVNef X
HY TCR) double Tg mice (Fig. 2A). Since upregulation of CD69 in
CD8þ SP thymocytes indicate that these cells have undergone
positive selection (Swat et al., 1993), we used this marker to followFig. 2. Positive selection of MHC class-I restricted CD8þ thymocytes: (A) Thymic FACS p
the gated events is shown as mean7SD (upper panel). Absolute cell numbers of differe
surface expression on thymocytes of OT-1 TcR Tg and (OT-1 TcR X CD4C/HIVNef ) double
T cells in spleen. Statistical analysis was performed by Student’s t-test. ***pr0.0005.the fate of CD8þ SP thymocytes in the presence of Nef. In (CD4C/
HIVNef X OT-1 TCR) double Tg mice, a larger proportion (64%) of
the CD8þ SP thymocytes were CD69hi than in OT-1 TCR single Tg
mice (45%) (Fig. 2B, upper panel), suggesting an accumulation of
cells with immature phenotype. The percentage of OT-1 TCRhiCD69lo
thymocytes, which represent mature thymocytes, was similar in
both the double and single Tg mice (Fig. 2B, lower panel). Also, the
CD8þ T cell numbers in the peripheral lymphoid organs was similar
in the double and single Tg mice (Fig. 2C).
Together, these results indicate that more DP cells receive a
positive selection signal in the presence of HIV-1 Nef to form CD8þ
SP thymocytes. However, it appears that not all of them develop toroﬁles of OT-1 TcR Tg and (OT-1 TcR X CD4C/HIVNef ) double Tg mice. Percentage of
nt thymocyte populations expressing OT-1 TcR are shown in lower panel. (B) CD69
Tg mice. Percentages are shown as mean7SD. (C) Absolute cell numbers of CD8þ
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CD8þ SP thymocytes. Furthermore, despite being sufﬁcient in
numbers, CD8þ thymocytes appear to have functional defects
which result in a delay in establishing the peripheral CD8þ T cell
compartment. Our data also suggest an additional Nef-mediated
developmental block of DN to DP thymocyte transition, as indicated
by increased numbers of DN and reduced numbers of DP thymo-
cytes in (CD4C/HIVNef X HY TCR) Tg mice (Fig. 1A and B).
Peripheral CD8þ T cells from Tg mice exhibit an activated phenotype
and increased proliferation in vivo
The generation of CD8þ T cells does not seem to be grossly
affected in HIV-1 Nef Tg mice and equal numbers of these cells areFig. 3. Activated phenotype of peripheral CD8þ T cells: (A) representative histogram p
gray line. (B) Bar graph representation of expression of activation markers on CD8þ T ce
PD-1 on CD4þ and CD8þ T cells from Tg and non-Tg mice. (D) Incorporation of BrdU
antibody. Histogram plot of one representative experiment is shown. (E) Bar graph show
vs HIV-1 Nef Tg mice. Statistical analysis was performed by Student’s t-test and p-valupresent in the peripheral lymphoid organs of Tg mice compared to
non-Tg control mice (Hanna et al., 1998; Priceputu et al., 2005). Cell
surface phenotype of peripheral LN CD8þ T cells from CD4C/HIVNef
Tg mice was determined by labeling cells with antibodies against
activation and development markers and analyzed by FACS. A larger
proportion of CD8þ T cells from Tg mice were CD44hi, as compared
to non-Tg control mice (Fig. 3A and B). The difference in cell surface
expression of other markers associated with activation, CD69, CD25,
CD45RB and CD62L, was less pronounced. A larger proportion of
CD8þ T cells from Tg mice were PD-1þ as compared to those from
non-Tg control mice, although this difference did not reach statis-
tical signiﬁcance (Fig. 3C). Also, the percentage of PD-1þ CD8þ T
cells was much lower than that of PD-1þ CD4þ T cells in the same
mice (Fig. 3C).lot showing CD44 surface expression in shaded area. Isotype control is shown by
lls in non-Tg vs HIV-1 Nef Tg mice (n¼9). (C) Bar graph representing expression of
in CD8þ T cells of peripheral LN analyzed by FACS after staining with anti-BrdU
ing increased incorporation of BrdU in CD8þ T cells of pLN and spleen from non-Tg
es are represented by stars (***po0.0001; **po0.01).
Fig. 4. In vitro stimulation and CD8þ T cell proliferation. CFSE labeled OT-1 TcR Tg
and (OT-1 TcR X CD4C/HIVNef ) double Tg total peripheral LN cells stimulated with
plate-bound anti-CD3 and 100 U/ml mouse IL-2 (A), with 5 mg/ml ConA (B) or with
1 mg/ml OVAp (C) in vitro for 3 days. Number of divisions is indicated on the top.
(D) Bar graph representation of percent of peripheral LN CD8þ T cells at different
divisions after in vitro stimulation with OVAp. (E) CFSE labeled ﬂow cytometry
sorted CD8þ T cells from OT-1 TcR Tg and (OT-1 TcR X CD4C/HIVNef) double Tg
peripheral LN stimulated with 1 mg/ml OVAp in vitro for 3 days in presence of
30,000 irradiated non-Tg splenocytes and 100 U/ml mouse IL-2. Number of
divisions is indicated on the top. Statistical analysis was performed by Student’s
t-test and p-values are shown.
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cells was associated with increased proliferation, we assessed cell
proliferation in vivo following labeling with BrdU provided indrinking water for a period of 2 weeks. Incorporation of BrdU in
newly synthesized DNA was revealed by FACS analysis of CD8þ T
cells in spleen and pLN. Increased proportion of BrdUþ CD8þ T
cells was found in CD4C/HIVNef Tg as compared to non-Tg mice
(Fig. 3D and E). A similar enhanced proliferation of CD8þ T cells
was also observed in mCD4/HIVNef Tg mice (Fig. 4D) which do not
express Nef in myeloid cells, in contrast to CD4C/HIVNef Tg mice
(Hanna et al., 2009). However, despite this enhanced cell prolif-
eration, the numbers of peripheral CD8þ T cells were not
increased in Tg mice, possibly due to increased cell death of Tg
CD8þ T cells (Priceputu et al., 2005).
Peripheral CD8þ T cells from Tg mice can proliferate normally
in vitro after stimulation
To determine the functional competence of peripheral CD8þ T
cells of CD4C/HIVNef Tg mice, total peripheral LN cells from (CD4C/
HIVNef X OT-1 TCR) double Tgmice were stimulated in vitrowith anti-
CD3 antibody and mouse IL-2, ConA or OVAp (SIINFEKL) peptide for 3
days and cell division was monitored by CFSE dilution of pre-loaded
cells, by gating on CD8þ T cells. When stimulated with anti-CD3mAb
or ConA (CD4C/HIVNef X OT-1 TCR) double Tg CD8þ T cells prolifer-
ated as efﬁciently as the control OT-1 TCR Tg CD8þ T cells stimulated
under similar conditions (Fig. 4A and B). Similar results were obtained
after anti-CD3 stimulation of peripheral LN cells from CD4C/HIVNef
and mCD4/HIVNef Tg mice (Fig. S2), or after ConA stimulation of
CD4C/HIVMutA splenocytes (Fig. S3A). Also, proliferation of non-Tg and
CD4C/HIVMutA Tg CD8þ T cells was similar in an allogenic MLR with
high number of BALB/c stimulator cells (Fig. S3B). These data suggest
that the signaling cascade activated by the direct engagement of TCR
functions normally in Tg cells.
In contrast, when the MLR assay was performed with fewer
stimulators, proliferation of CD8þ T cells from Tgmice was decreased
(Fig. S3B). Also, when stimulated with OVAp, CD8þ T cells mixed in
total LN cells from (CD4C/HIVNef X OT-1 TCR) double Tg mice were
found to proliferate at a signiﬁcantly slower rate than control OT-1
TCR Tg CD8þ T cells (Fig. 4C and D). This latter proliferation defect of
Tg CD8þ T cells could result from the altered microenvironment of
peripheral LN, containing dendritic cells and depleted CD4þ T cells
whose functions are impaired in the CD4C/HIVNef Tg mice (Weng
et al., 2004; Poudrier et al., 2003). To test this hypothesis, we puriﬁed
CD8þ T cells from (CD4C/HIVNef X OT-1 TCR) double and OT-1 TCR
single Tg peripheral LN by cell sorting with negative staining and
stimulated them in vitrowith OVAp in the presence of irradiated non-
Tg splenocytes (as antigen presenting cells) and mouse IL-2 for 3
days. Both single Tg and double Tg CD8þ T cells proliferated with
similar efﬁciency in this context (Fig. 4E). These results indicate that
CD8þ T cells from CD4C/HIVNef Nef Tg mice have the ability to
proliferate as efﬁciently as non-Tg CD8þ T cells in vitro.
Tg mice are able to mount an efﬁcient primary CD8þ T cell response
against LCMV
To assess CD8þ T cell function in vivo, CD4C/HIVNef Tg and
non-Tg control mice were infected intraperitoneally (i.p.) with
106 pfu of the Armstrong strain LCMV known to cause an acute
infection and induce a strong CD8þ T cell response in mice. Virus
titers were determined in the spleen of infected mice on day 3
and 8 post-infection (p.i.). On day 3 p.i., over 106 pfu LCMV per
gram of spleen was detected in both Tg and non-Tg mice, whereas
virus titres were down by 1000 fold on day 8 p.i. in Tg as well as
non-Tg mice (Fig. 5A). LCMV gp33 tetramer staining and FACS
analysis of spleen CD8þ T cells on day 7 p.i. showed no signiﬁcant
difference in Tg vs. non-Tg mice for the numbers of gp33-speciﬁc
CD8þ T cells (Fig. 5B and C), and these exhibited an activated
CD62Llow phenotype (Fig. 5B), consistent with their being effector
Fig. 5. CD8þ T cell response and virus clearance in LCMVArmstrong infected mice: (A) LCMV titers in the spleen of non-Tg and HIV-1 Nef Tg mice on day 3 and day 8 post-
infection (p.i.). Mice were infected with 106 pfu LCMVArmstrong intraparitoneally. Virus titer per gram of spleen is represented as log10 scale. Horizontal bars represent the
mean values. (B) LCMV gp33-speciﬁc effector CD8þ T cells in spleen of uninfected non-Tg, LCMVArmstrong infected non-Tg and Tg mice on day 7 p.i. Total cell number
(C) and LCMV gp33-speciﬁc effector CD8þ T cell numbers (D) in spleen of LCMVArmstrong infected non-Tg and Tg mice on day 7 p.i.
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cells (Poudrier et al., 2001) and defective dendritic cell functions
(Poudrier et al., 2003), CD4C/HIVNef Tg mice have conserved the
ability to mount a robust primary CD8þ T cell response against
LCMVArmstrong and to clear the virus.Depletion of LCMV-speciﬁc CD62Lþ CD8þ memory T cells in Tg mice
Since the primary response against LCMV appears normal in
CD4C/HIVNef Tg mice, we then investigated whether these mice
are able to generate and maintain long term LCMV-speciﬁc CD8þ
memory T cells. Tg and non-Tg control mice were infected with
LCMV as before and were analyzed, more than 2 months after
infection, by FACS with LCMV gp33-tetramer staining to detect
the presence of LCMV gp33-speciﬁc CD8þ memory T cells.
Signiﬁcantly reduced numbers of LCMV gp33-speciﬁc CD8þ
memory T cells were present in the spleen of Tg compared to
non-Tg mice (Fig. 6A and B). The same trend was also apparent in
peripheral LN (Fig. 6D and E). Also, the proportion of LCMV gp33-
speciﬁc CD62Lþ CD8þ Tg memory T cells, which may correspond
to central memory subset, was signiﬁcantly decreased in both Tg
spleen (Fig. 6A and C) and pLN (Fig. 6D and F). Interestingly, the
percentage of CD62L subset, likely representing effector mem-
ory T cells, was increased, specially in LN (Fig. 6A, C and D, F).
These results strongly suggest that the generation and/or main-
tenance of speciﬁc subsets of CD8þ memory T cells are impaired
in these Tg mice.CD8þ T cells from Tg mice efﬁciently form memory cells in vitro
The lower number of LCMV gp33-speciﬁc CD62LþCD8þ mem-
ory T cells in Tg mice could reﬂect a cell-intrinsic defect in their
generation. We used an in vitro assay allowing the formation of
CD8þ memory T cells to test this hypothesis (Pulle et al., 2006).
CD8þ T cells from OT-1 TCR Tg and (OT-1 TcR X CD4C/HIVNef )
double Tg mice were stimulated by non-Tg CD8þ T cell-depleted
splenocytes in the presence of OVAp, followed by differentiation
to memory T cells in presence of IL-15. Generation of CD44þ
CD62þ memory CD8þ T cells was similar in this assay whether
the CD8þ T cells came from non-Tg or Nef Tg mice (Fig. 7),
suggesting that these cells exhibit no intrinsic defects of differ-
entiation towards a memory phenotype.
Partial rescue of the LCMV-speciﬁc Tg CD62Lþ CD8þ T cell depletion
by adoptive transfer of naive non-Tg CD4þ T cells
It is known that CD4þ helper T cell functions are necessary
for the maintenance of CD8þ memory T cells in mice (Sun et al.,
2004). The impaired CD4þ helper T cell functions, already
documented in Tg mice (Poudrier et al., 2001), could be respon-
sible for the CD8þ memory T cell phenotype. We next attempted
to restore the impaired CD8þ memory T cells by transferring
naı¨ve non-Tg CD4þ T cells to Tg mice prior to infection with
LCMVArmstrong. This resulted in an increased numbers and percen-
tage in spleen (Fig. 6A–C), and enhanced percentage in LN (Fig. 6D
and F) of CD62Lþ CD8þ memory T cells. This partial recovery
suggests that the impaired CD8þ memory T cell phenotype of
Fig. 6. LCMV-speciﬁc CD8þ memory T cells in LCMVArmstrong infected mice. LCMV gp33-speciﬁc memory CD8þ T cells in spleen (A–C) and pLN (D–F) of uninfected non-Tg,
LCMVArmstrong infected non-Tg, HIV-1 Nef Tg and HIV-1 Nef Tg mice to which naı¨ve non-Tg CD4þ T cells were adoptively transferred prior to infection. Mice were infected
with 106 pfu LCMVArmstrong intraparitoneally. FACS analysis was performed 42 months p.i. on spleen and pLN. Bar graphs showing LCMV gp33-speciﬁc memory CD8þ T
cell numbers in spleen (B) and pLN (E) of uninfected and LCMVArmstrong infected mice more 42 months after primary infection. Bar graphs representing skewed LCMV
gp33-speciﬁc memory CD8þ T cell phenotype in spleen (C) and pLN (F) of LCMV infected HIV-1 Nef Tg vs. non-Tg mice and its partial restoration by adoptive transfer of
naı¨ve non-Tg CD4þ T cells to the HIV-1 Nef Tg mice.
M.M. Ahmed Rahim et al. / Virology 438 (2013) 84–97 91CD4C/HIVNef Tg mice is due at least in part to decreased CD4þ T
cell helper functions.Discussion
We studied the CD8þ T cell compartment of CD4C/HIVNef Tg
mice, which express HIV-1 Nef mainly in CD4þ T cells and cells of
macrophage/monocytes/dendritic lineage, but only in a very small
proportion of CD8þ T cells. This pattern of expression is consistent
with the low levels of infected CD8þ T cells measured in HIV-1
infected individuals (Cochrane et al., 2004; Imlach et al., 2001; Sahaet al., 2001). Activation of human CD8þ T cells induces CD4 gene
expression making them targets for HIV infection (Flamand et al.,
1998; Yang et al., 1998; Imlach et al., 2001). CD4-expressing CD8þ T
cells represent o3% of the peripheral blood mononuclear cells
(PBMC) in HIV-1 infected individuals and are productively infected
with HIV-1 at levels approaching that of CD4þ T cells (Cochrane
et al., 2004; Imlach et al., 2001; Saha et al., 2001). Peripheral CD8þ T
cells of CD4C/HIVNef Tg mice show an effector/memory phenotype,
based on CD44 cell surface expression (Weng et al., 2004). Such
condition is likely to promote some activity of the Tg regulatory
sequences of the human CD4 gene (CD4C) and Nef expression, thus
mimicking their expression in human activated CD8þ T cells.
Fig. 7. CD8þ T cells from Tg mice efﬁciently form memory cells in vitro. CD8þ T cells from OT-1 TCR Tg and (OT-1 TcR X CD4C/HIVNef ) double Tg mice were stimulated by
WT CD8þ T cell-depleted splenocytes in the presence of OVA-peptide (SIINFEKL 10 mg/ml), followed by IL-15. Then, cells were labeled with antibodies against Va2, CD8,
CD44, and CD62L, and were analyzed by FACS. FACS proﬁles from one of two experiments giving similar results. Numbers in proﬁles represent percentages and absolute
cell numbers in millions.
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CD4C/HIVNef Tg mice
HIV-1 infects human thymus and impairs thymopoiesis, as
observed in SCID-hu mouse model (McCune et al., 1991) and HIV-1
infected infants (Gaulton et al., 1997; Ho Tsong et al., 2008; Kourtis
et al., 1996). CD4C/HIVNef Tg mice express Nef at high levels in the
thymus, particularly in the CD4þ CD8þ DP thymocytes, and show
impaired selection and lineage commitment of CD4þ SP thymocytes
(Chrobak et al., 2010). We investigated CD8þ SP thymocyte devel-
opment in these Tg mice bred with TCR Tg (HY and OT-1 TCR Tg)
mice commonly used as models to study thymocyte selection
processes. To our surprise, we found that both negative and positive
selections of CD8þ T cells proceeded apparently normally, in CD4C/
HIVNef Tg mice. The expression of Nef in male HY TCR Tg mice did not
prevent the elimination of HY-speciﬁc DP thymocytes. In female HY
and OT-1 TCR Tg mice, expression of Nef did not impair positive
selection of CD8þ T cells. In particular, the proportion of mature
CD8þ SP T cells with TCRabhiCD69lo phenotype was not affected.
However, some abnormalities of the thymic CD8þ T cell subset were
noted: (a) in female OT-1/Nef Tg mice, a larger proportion of CD8þ SP
thymocytes remains immature and accumulates in the thymus; (b)
appearance of peripheral CD8þ T cells in female HY TCR Tg mice was
intriguingly delayed; (c) decreased numbers of spleen Tg CD8þ T cells
were observed in hosts transplanted with fetal liver cells. The cellular
and molecular basis of these CD8þ T cell phenotypes remain to be
elucidated. Their presence suggests possible additional effects of Nef
in the generation and/or maintenance of these cells. Nevertheless, in
contrast to its effect on CD4þ T cells (Chrobak et al., 2010), expression
of Nef in Tg thymocytes does not grossly impair the development ofCD8þ T cells, despite the fact that their precursors, the CD4þCD8þ
DP thymocytes, exhibit a number of signiﬁcant problems (already
documented) related to Nef expression: CD4 downregulation,
enhanced apoptosis, increased PAK2 and lck activity and impaired
TcR-mediated lck signaling (Chrobak et al., 2010; Hanna et al., 1998;
Vincent et al., 2006). CD8þ T cell fate may be less dependent on these
pathways than that of CD4þ T cells. It is known that CD4 gene-
deﬁcient mice do not show defects in CD8þ T cell development
(Rahemtulla et al., 1991), and that CD8 lineage speciﬁcation is largely
independent of lck (Legname et al., 2000) and occurs in absence of
TcR signaling (Park et al., 2010).Peripheral CD8þ T cells from CD4C/HIVNef Tg mice respond well to
antigenic stimulation in vitro and in vivo
The peripheral CD8þ T cells of Nef-expressing mice show
activated phenotype and enhanced division in vivo. This is similar
to what was reported for CD4þ T cells of these mice (Weng et al.,
2004). Our experiments with OT-1 Tg mice also indicate that
activation of this T cell subset is independent of Ag encounter. The
increased in vivo division of Tg CD8þ T cells appears to be counter
balanced by increased apoptotic cell death previously documen-
ted in these cells (Priceputu et al., 2005); hence no net increase in
CD8þ T cells numbers was observed (Priceputu et al., 2005). The
enhanced activation and proliferation of Tg CD8þ T cells mimicks
the increased activation and proliferation of CD8þ T cells reported
in HIV-1 or SIV infection (Sodora and Silvestri, 2008; Giorgi et al.,
1993; Mohri et al., 1998; Sachsenberg et al., 1998; Rosenzweig
et al., 1998).
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in vitro stimuli is also maintained in Nef Tg mice. We observed
impaired proliferation of Tg CD8þ cells only when they were
stimulated with OVAp peptide in the presence of total Tg peripheral
LN cells. In contrast, their proliferation was normal in response to
OVAp stimulation in presence of non-Tg irradiated splenocytes used
as antigen-presenting cells. These results strongly suggest that defects
of other Tg immune cells affect CD8þ T cell responses in vitro. We
have indeed reported that Tg dendritic cells (DC), show downregula-
tion of class I MHC and have a decreased capacity to present antigens
and to stimulate a mixed lymphocyte reaction (Poudrier et al., 2003).
HIV-1 Nef has been shown to downregulate MHC-I surface expression
on human DCs and thus impair presentation of antigens to HIV-
speciﬁc CD8þ T cells (Andrieu et al., 2001). Thus, the signaling
pathway downstream of TCR appears to be unaffected in CD8þ T
cells of Tg mice, possibly reﬂecting the fact that only a small
proportion of these cells are expressing Nef at low levels. In addition,
CD8þ T cells from CD4C/HIVNef Tg mice have conserved another
in vivo function, the capacity to generate a strong acute CD8þ T cell
response against LCMVArmstrong and to clear the virus as efﬁciently as
non-Tg mice despite their lower CD4þ T helper activity (Poudrier
et al., 2001). It has been shown that CD4þ T cells are not essential for
the control of acute infection by LCMVArmstrong but are required for
the resolution of chronic LCMV infection (Ahmed et al., 1988;
Matloubian et al., 1994). Longer maintenance of CTL responses
against other viruses than HIV-1 has also been noted during AIDS
development (Carmichael et al., 1993; Geretti et al., 1996).
Depletion of CD8þ memory T cells in CD4C/HIVNef Tg mice is partly
due to lack of CD4þ T helper activity
Following activation and expansion of CD8þ T cells in response to
antigenic stimulation in vivo, the majority of effector CD8þ T cells die
by apoptosis, whereas a minority of them (5–10%) differentiates
into a small but long-lasting population of CD8þ memory T cells
(Wherry and Ahmed, 2004). LCMV-speciﬁc CD8þ memory T cells are
detected in normal mice several weeks after viral clearance and are
distinguished into three major subsets based on the surface coex-
pression of CD62L and CCR7: CD62LþCCR7þ central memory (TCM),
CD62LCCR7þ effector memory (TEM) and CD62L
CCR7 intermedi-
ate memory (TIM) T cells (Wherry et al., 2003; Unsoeld and Pircher,
2005). Lower numbers of LCMV-speciﬁc memory CD62LþCD8þ T
cells are generated in Nef Tg compared to non-Tg mice. These are
likely to represent central memory CD8þ T cells. These latter were
found to be decreased during HIV infection (Ladell et al., 2008).
Moreover, the phenotype of memory cells in Nef Tg mice is skewed
towards the CD62L subpopulation, suggesting an impaired matura-
tion with accumulation of TEM at the expense of central memory
subset (Wherry et al., 2003; Cui and Kaech, 2010). A maturation block
of HIV or SIV-speciﬁc memory CD8þ T cells has been reported during
HIV-1 or SIV infection with accumulation of pre-terminally differ-
entiated subset of memory CD8þ T cells (Champagne et al., 2001;
Mueller et al., 2007). Depletion of EBV-speciﬁc memory CD8þ T cells
(Piriou et al., 2005b) and impaired maturation of EBV-speciﬁc CD8þ T
cells (van Baarle et al., 2002) have also been reported. Moreover,
CD8þ T cell responses to other pathogens have been found to be
reduced and/or dysfunctional in HIV or SIV-infection (Van Baarle
et al., 2001; Piriou et al., 2005b; Geretti et al., 1996; Kaur et al., 2003;
van Baarle et al., 2002; Bronke et al., 2005). These observations are
relevant to the present study showing defective memory CD8þ T cell
responses to a virus (LCMV) unrelated to HIV-1.
Our data show that Nef Tg CD8þ T cells can efﬁciently
differentiate into memory T cells in vitro. We also found that
the impaired maturation and depletion of memory CD8þ T cells
in Nef Tg mice could be partially rescued by adoptive transfer of
non-Tg naı¨ve CD4þ T cells, and thus appears to be caused by lackof CD4þ T helper activity, previously documented in these Tg
mice (Poudrier et al., 2001). This interpretation is consistent with
the essential role of CD4þ T cell help for the generation of
memory CD8þ T cells in mice (Sun and Bevan, 2003; Shedlock
and Shen, 2003; Kaech and Ahmed, 2003). It is also concordant
with data from human or simian infection. Indeed, a correlation
was observed in HIV or SIV-infected individuals between loss of
CD4þ helper cells and depletion of CD8þ CTL against viruses
other than HIV (Bronke et al., 2005; van Baarle et al., 2002;
Spiegel et al., 2000; Komanduri et al., 2001; Kaur et al., 2003;
Kostense et al., 2002a). In addition, an increase of anti-EBV CD8þ
T cell response was observed in AIDS patients under anti-
retroviral therapy (Kostense et al., 2002a; Dalod et al., 1999).
Our experimental observation in Nef Tg mice most likely models
the critical role of CD4þ helper functions in human HIV infection
(Altfeld and Rosenberg, 2000; Rosenberg et al., 1997). However,
rescue of memory CD8þ T cell phenotypes with non-Tg CD4þ T
cells was not complete, suggesting the presence of additional
defects. Persistence of HIV-speciﬁc CD8þ CTL defects in the
presence of functional CD4þ T cell response has been described
(Migueles et al., 2009). Possibly LN structure, found to be
abnormal in these Nef Tg mice (Hanna et al., 1998, 2004, 2006;
Priceputu et al., 2005, 2007; Poudrier et al., 2001, 2003) could be
involved. Such pathological changes have been hypothesized to
adversely affect T cell memory during HIV infection (Lederman
and Margolis, 2008).
Although the CD4C/HIVNef Tg mice develop an AIDS-like disease
very similar to human AIDS, this model has its limitations and
is unlikely to reproduce all the CD8þ T cell changes seen in HIV-
infected individuals. First, changes related to a chronic anti-HIV CD8þ
T cell response cannot be scored in these mice, because Nef is most
likely tolerized due to its early expression in the thymus. Second,
LCMV Armstrong infection is an acute infection model, with viral
clearance occurring around one week after infection, again different
from the chronic nature of HIV infection in patients. Thirdly, the
contribution of other HIV genes has not been evaluated in CD4C/
HIVNef Tg mice expressing only Nef. The products of other HIV genes,
alone or in collaboration with Nef, may affect CD8þ T cell develop-
ment and function. Despite these limitations, the CD4C/HIVNef Tg
mice have yielded valuable insights into the effects of Nef on CD8þ
T cells.
In conclusion, unlike the CD4þ T cells, CD8þ T cell development
in CD4C/HIVNef Tg mice is grossly normal, despite the severe
abnormalities of their precursors, the DP thymocytes. Some functions
of Tg CD8þ T cells also appear to be maintained, in particular their
in vitro proliferative response and their capacity to generate a normal
primary memory response to LCMV in vivo. However, the generation
and/or maintenance of LCMV-speciﬁc CD8þ memory T cells are
impaired in these Tg mice, partly due to lack of CD4þ helper
functions. The CD4C/HIVNef Tg mice could be a valuable tool to
investigate the cellular and molecular pathways leading to HIV-
mediated defective CD8þ memory T cell responses.Materials and methods
Mice
CD4C/HIVNef (previously designated CD4C/HIVMutG), CD4C/
HIVMutA and mCD4/HIVNef Tg mice have been described (Hanna
et al., 1998, 2009). HY TCR (Teh et al., 1988) and OT-1 TCR (Clarke
et al., 2000) Tg mice were provided by Dr. Vibhuti Dave (IRCM,
Montreal) and were bred with CD4C/HIVNef Tg mice to obtain
double Tg mice. All mice were maintained on a C57BL/6 back-
ground and littermates between the ages of 6 and 8 weeks for
older mice and 1–2 weeks for younger mice were used in the
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pathogen-free conditions and all experiments were approved by
the Institutional Animal Ethics Committee.Antibodies and reagents
Fluorescein isothiocyanate (FITC), phycoerythrin (PE) and
allopycocyanin (APC)-labeled mAb, including anti-CD4, CD8,
TcRb, TCRgd, CD69, CD25, CD44, CD45RB, CD62L were purchased
from Cedarlane. PE-labeled anti-HY TCR (T3.70) was from
eBioscience and FITC-labeled anti-OT-1 (Va2) TCR was from
Cedarlane. The hybridoma producing hamster anti-mouse CD3e
(145-2C11) was purchased from American Type Culture Collec-
tion (ATCC; Rockville, MD). The anti-CD3 mAb was puriﬁed with a
protein G afﬁnity column. Mouse IL-2 and IL-15 were purchased
respectively from Roche Diagnostics GmbH and R&D systems.
Irrelevant rat IgG1, rat IgG2a, rat IgG2b and Armenian hamster
IgG1 were used as isotype controls. Anti-PD-1(PE) mAb and
bromodeoxyuridine (BrdU)-FITC ﬂow kit were purchased from
BD Pharmingen. OVAp peptide (OVAp) was a gift from Dr. V. Dave
(IRCM, Montreal). LCMVArmstrong, VL5 hybridoma cells, BHK21 and
MC57G cells were gifts from Dr. C. Perreault (University of
Montreal, Montreal) and Dr. W.-K. Suh (IRCM, Montreal). LCMV
gp33-speciﬁc tetramer was purchased from Immunomics Divi-
sion, Beckman Coulter (San Diego, CA).Flow cytometric analysis
Immunostaining was performed as described previously
(Weng et al., 2004; Priceputu et al., 2007). FACS Calibur and
Cellquest software (Becton Dickinson) were used for ﬂow cyto-
metric analysis.Puriﬁcation of CD8þ T cells
CD8þ T cells were puriﬁed by cell sorting with MoFlo cell
sorter (Cytomation Inc.). Peripheral LN cells were stained with PE-
labeled MHC-II, anti-CD4, anti-B220 and anti-TCRgd as described
previously (Weng et al., 2004). The CD8þ T cells were sorted by
gating on PE-negative population.CFSC ﬂuorescent-dye cell labeling and proliferation assays
CFSE labeling was performed as described previously (Weng
et al., 2004). CFSE-labeled cells were plated at 105 cells/well in a
96-well microtiter plates (NUNCTM) in complete RPMI medium
and stimulated with plate bound anti-CD3 (5 mg/ml) and recom-
binant mouse IL-2 (100 U/ml), ConA (5 mg/ml) or OVAp (1 mg/ml)
for 3 days. For stimulation of puriﬁed CD8þ T cells with OVAp,
splenocytes from non-Tg mice irradiated at 2500 rad were used as
antigen presenting cells. Unstimulated cells were used as CFSE
baseline control. CFSE-labeled cells were analyzed by ﬂow
cytometry.Fetal liver (FL) cell transplantation
Donors: Fetal livers from non-Tg (CD45.1þ CD45.2þ) and Tg
(CD45.1þ CD45.2þ) 14.5-day-old embryos (E14.5) were har-
vested and single cell suspensions were made. Hosts: 8–12-
week-old C3H/HeN (H-2k) (CD45.2þ) non-Tg or Tg mice were
lethally-iradiated (950 rad) and were injected via the tail vein
with 4106 FL cells. Chimeras were analyzed 3 months after
transplantation.Detection of cell proliferation in vivo
This procedure has been described previously (Weng et al.,
2004). Brieﬂy, it involves the detection by FACS analysis of
bromodeoxyuridine (BrdU) incorporated into cellular DNA of
animals previously fed with BrdU in their drinking water
(0.8 mg/ml) for 12 days. Lymphoid organs were collected and cell
surface staining was ﬁrst performed with anti-CD4 and anti-CD8
mAb, followed by an intracellular staining with FITC-labeled anti-
BrdU antibody for detection of DNA synthesis.
LCMV infections
LCMVArmstrong was produced on BHK21 cells and titrated on
MC57G cells by immunological focus assay (Battegay et al., 1991).
Mice were infected with 106 pfu of LCMV intraperitoneally (i.p.).
All experiments were carried out in containment level 2 (CL2)
facility. LCMV titers in spleen of infected mice were determined
by immunological focus assay on MC57G cells (Battegay et al.,
1991). LCMV gp33-speciﬁc tetramer staining was performed
following manufacturer’s instructions.
In vitro CD8þ memory T cell generation assay
We modiﬁed a previously published assay (Pulle et al., 2006).
Cultures containing 15% puriﬁed (positive selection using the
AutoMACS separator and CD8 biotin and anti-biotin microbeads)
CD8þ T cells from single OT-1 and double OT-1 Nef Tg mice and
85% of CD8 depleted (AutoMACS separation using CD8 biotin and
and anti-biotin microbeads) splenocytes in the presence of OVA-
peptide (SIINFEKL 10 mg/ml) were setup in complete RPMI media
at 5106 cells/ml. After primary stimulation performed as pub-
lished, cells were cultured in IL-15 according to the previously
published protocol. At the end of the culture FACS analysis was
performed.
Quantitative RT-PCR
To detect transgene expression, quantitative RT-PCR was
performed on RNA isolated from sorted CD4þ and CD8þ T cells
using QuantiTect SYBR Green PCR Kit (Qiagen) following manu-
facturer’s instructions. The sequence of primers used for detecting
HIV transcripts were CCCCACTGGGCTCCTGGTTGCAGC located in
exon 1 of the human CD4 gene and CAGTCGCCGCCCCTCGCCTCTT
speciﬁc for HIV genome.
Statistics
Statistical analysis by Student’s t-test was performed as
described previously (Weng et al., 2004).Acknowledgments
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